Cite
APA Citation
Lee, A. Y., Lee, C. S., Egan, C. A., Bailey, C., Johnston, R. L., Natha, S., Hamilton, R., Khan, R., Al-Husainy, S., Brand, C., Akerele, T., Mckibbin, M., Downey, L., & Tufail, A. (2017). uK AMD/DR EMR REPORT IX: comparative effectiveness of predominantly as needed (PRN) ranibizumab versus continuous aflibercept in UK clinical practice. British journal of ophthalmology, 101(12), 1683–1688. http://access.bl.uk/ark:/81055/vdc_100135551372.0x000054